NCT03129269View on ClinicalTrials.gov

Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults

NAActive, not recruitingINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

January 2, 2017

Primary Completion Date

January 2, 2026

Study Completion Date

December 31, 2026

Conditions
Frail Elderly
Interventions
PROCEDURE

MRI and PET scan

Neuroimaging with MRI and PET scan Amyloid tracer : For PET-scans, 4 MBq/kg of \[18F\]AV-45 will be injected into each subject in an intravenous bolus.

Trial Locations (1)

31059

Toulouse University Hospital (CHU de Toulouse), Toulouse

All Listed Sponsors
collaborator

MSDAVENIR

UNKNOWN

lead

University Hospital, Toulouse

OTHER

NCT03129269 - Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults | Biotech Hunter | Biotech Hunter